1460772662-896b3e5a-609f-41e7-b9ef-04a460080179

1-27. (canceled)
28. A compound of the formula I:
wherein:
A is selected from the group consisting of phenyl, napthyl, azetidinyl, benzoxazolyl, benzofuranyl, benzimidazolyl, chromenyl, dihydroindenyl, dihydroisoquinolinyl, isoquinolinyl, imidazolyl, imidazopyridinyl, indanyl, indazolyl, indolyl, oxadiazolyl, purinyl, pyridyl, pyrimidinyl, quinolinyl, tetrahydroisoquinolinyl, and tetrazolyl, which is unsubstituted or substituted with oxo;
X is selected from the group consisting of:
(1) a bond;
(2) \u2014O\u2014,
(3) \u2014S\u2014,
(4) \u2014SO2\u2014,
(5) \u2014NH\u2014,
(6) \u2014N(C1-3alkyl)-,
(7) \u2014O-phenyl-,
(8) \u2014S-phenyl-,
(9) \u2014S\u2014C1-3 alkyl-phenyl-,
(10) -phenyl-, and
(11) -piperazinyl-;

Y is selected from the group consisting of:
(1) \u2014O\u2014,
(2) \u2014NH(CO)\u2014, and
(3) a bond;

R1 is selected from the group consisting of:
(1) hydrogen,
(2) C1-6alkyl, which is unsubstituted or substituted with a substituent selected from:
(a) halogen,
(b) hydroxyl, and
(c) phenyl, wherein the phenyl is unsubstituted or substituted with 1-5 substituents independently selected from halogen, cyano, CF3, hydroxyl, C1-6alkyl, and OC1-6alkyl,

(3) C3-7cycloalkyl, which is unsubstituted or substituted with halogen, hydroxyl or phenyl, and
(4) phenyl, wherein the phenyl is unsubstituted or substituted with 1-5 substituents independently selected from halogen, hydroxyl, cyano, CF3, C1-6alkyl, and OC1-6alkyl, wherein the C1-6alkyl and OC1-6alkyl are linear or branched and optionally substituted with 1-5 halogen;

R2 is selected from the group consisting of:
(1) halogen,
(2) hydroxyl,
(3) \u2014OC1-6alkyl, and
(4) C1-6alkyl, which is unsubstituted or substituted with halogen, hydroxyl or phenyl;

R3 is selected from the group consisting of:
(1) halogen, and
(2) C1-6alkyl, which is unsubstituted or substituted with halogen, hydroxyl or phenyl;

R4 may include multiple substituents and is independently selected from the group consisting of:
(1) hydrogen,
(2) halogen,
(3) C1-6alkyl, unsubstituted or substituted with halogen, \u2014CN, \u2014COC1-6alkyl or
\u2014CO2C1-6alkyl,

(4) \u2014O\u2014C1-6alkyl,
(5) phenyl,
(6) pyridyl,
(7) thiazolyl,
(8) \u2014CN, and
(9) hydroxyl,
or R4 may be joined to the phenyl ring at an adjacent carbon to form a dihydrofuranyl ring;

m is an integer selected from 0, 1, 2 and 3;
n is an integer selected from 0, 1, 2, 3, 4, 5 and 6;

or a pharmaceutically acceptable salt thereof.
29. The compound of claim 28 wherein A is phenyl.
30. The compound of claim 28 wherein A is pyridyl.
31. The compound of claim 28 wherein X is \u2014O\u2014.
32. The compound of claim 28 wherein X is \u2014S\u2014.
33. The compound of claim 32 wherein A is pyridyl and X is \u2014S\u2014.
34. The compound of claim 28 wherein X is a bond and Y is \u2014O\u2014.
35. The compound of claim 28 wherein X is \u2014O-phenyl-.
36. The compound of claim 28 wherein X is -phenyl-.
37. The compound of claim 28 wherein R1 is C1-6alkyl.
38. The compound of claim 37 wherein R1 is CH2CH(CH3)2.
39. The compound of claim 28 wherein R2 is hydroxyl.
40. The compound of claim 28 wherein R3 is methyl.
41. The compound of claim 28 wherein R4 is hydrogen.
42. The compound of claim 28 wherein m is 0.
43. The compound of claim 28 wherein n is 1.
44. The compound of claim 28 wherein n is 29.
45. A compound which is selected from the group consisting of:
7-{4-3-hydroxy-2-methyl-4-(3-methyl-butyryl)-phenoxy-butoxy}-chromen-2-one;
1-2-hydroxy-3-methyl-4-(4-phenoxy-butoxy)-phenyl-3-methyl-butan-1-one;
1-3-bromo-2-hydroxy-4-(4-phenoxy-butoxy)-phenyl-3-methyl-butan-1-one;
1-{2-hydroxy-3-methyl-4-4-(pyridin-3-yloxy)-butoxy-phenyl}-3-methyl-butan-1-one;
1-{2-hydroxy-3-methyl-4-4-(pyridin-2-yloxy)-butoxy-phenyl}-3-methyl-butan-1-one;
1-{2-hydroxy-3-methyl-4-4-(pyridin-4-yloxy)-butoxy-phenyl}-3-methyl-butan-1-one;
1-{2-hydroxy-3-methyl-4-3-(pyridin-3-yloxy)-propoxy-phenyl}-3-methyl-butan-1-one;
1-{2-hydroxy-4-4-(2-methoxy-phenoxy)-butoxy-3-methyl-phenyl}-3-methyl-butan-1-one;
7-{4-2-bromo-3-hydroxy-4-(3-methyl-butyryl)-phenoxy-butoxy}-chromen-2-one;
1-{3-bromo-2-hydroxy-4-4-(pyridin-3-yloxy)-butoxy-phenyl}-3-methyl-butan-1-one;
1-{2-hydroxy-3-methyl 4-5-(pyridin-3-yloxy)-pentyloxy-phenyl}-3-methyl-butan-1-one;
1-{4-4-(5-chloro-pyridin-3-yloxy)-butoxy-2-hydroxy-3-methyl-phenyl}-3-methyl-butan-1-one;
1-{4-4-(3-fluoro-phenoxy)-butoxy-2-hydroxy-3-methyl-phenyl}-3-methyl-butan-1-one;
1-{2-hydroxy-3-methyl-4-4-(3-trifluoromethyl-phenoxy)-butoxy-phenyl}-3-methyl-butan-1-one;
1-{2-hydroxy-4-4-(4-methoxy-phenoxy)-butoxy-3-methyl-phenyl}-3-methyl-butan-1-one;
1-{4-4-(3-chloro-phenoxy)-butoxy-2-hydroxy-3-methyl-phenyl}-3-methyl-butan-1-one;
1-{2-hydroxy-3-methyl-4-4-(pyrimidin-2-yloxy)-butoxy-phenyl}-3-methyl-butan-1-one;
1-{4-4-(2-fluoro-phenoxy)-butoxy-2-hydroxy-3-methyl-phenyl}-3-methyl-butan-1-one;
1-{4-4-(2,3-difluoro-phenoxy)-butoxy-2-hydroxy-3-methyl-phenyl}-3-methyl-butan-1-one;
1-{2-hydroxy-4-2-(isoquinolin-7-yloxy)-ethoxy-3-methyl-phenyl}-3-methyl-butan-1-one;
1-{2-hydroxy-3-methyl-4-4-(naphthalen-2-yloxy)-butoxy-phenyl}-3-methyl-butan-1-one;
1-{4-4-(2,3-dihydro-1H-inden-5-yloxy)butoxy-2-hydroxy-3-methylphenyl}-3-methylbutan-1-one;
6-{4-3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxybutoxy}indan-1-one;
1-(3-bromo-2-hydroxy-4-{3-(pyridin-3-yloxy)benzyloxy}phenyl)-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(4-pyridin-4-ylpiperazin-1-yl)butoxyphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(4-pyridin-2-ylpiperazin-1-yl)butoxyphenyl}-3-methylbutan-1-one;
1-{4-4-(3,4-dihydroisoquinolin-2(1H)-yl)butoxy-2-hydroxy-3-methylphenyl}-3-methylbutan-1-one;
7-(3-{2-bromo-3-hydroxy-4-(3-methylbutanoyl)phenoxymethyl}phenoxy)-2H-chromen-2-one;
1-{3-bromo-4-4-(2,3-difluorophenoxy)butoxy-2-hydroxyphenyl}-3-methylbutan-1-one;
1-2-hydroxy-3-methyl-4-(4-{methyl(6-methylpyridin-2-yl)methylamino}butoxy)phenyl-3-methylbutan-1-one;
7-{4-3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxybutoxy}-4-methyl-2H-chromen-2-one;
7-{4-3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxybutoxy}-4-(trifluoromethyl)-2H-chromen-2-one;
1-{2-hydroxy-3-methyl-4-4-(2-pyridin-2-yl-1H-benzimidazol-1-yl)butoxyphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-4-4-(1H-imidazo4,5-bpyridin-1-yl)butoxy-3-methylphenyl}-3-methylbutan-1-one;
1-(4-{4-(2-chloropyridin-3-yl)oxybutoxy}-2-hydroxy-3-methylphenyl)-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{4-(2-methylpyridin-3-yl)oxybutoxy}phenyl)-3-methylbutan-1-one;
1-{4-4-({2-(dimethylamino)methylpyridin-3-yl}oxy)butoxy-2-hydroxy-3-methylphenyl}-3-methylbutan-1-one;
6-{4-3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxybutoxy}-4-methyl-2H-chromen-2-one;
7-{4-3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxybutoxy}-3,4,8-trimethyl-2H-chromen-2-one;
1-(2-hydroxy-3-methyl-4-{4-(6-methylpyridin-3-yl)oxybutoxy}phenyl)-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{4-4-(1,3,4-oxadiazol-2-yl)phenoxybutoxy}phenyl)-3-methylbutan-1-one;
2,3-difluoro-4-{4-3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxybutoxy}benzonitrile;
1-{2-hydroxy-3-methyl-4-4-(pentafluorophenoxy)butoxyphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(2,3,5,6-tetrafluorophenoxy)butoxyphenyl}-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{4-(5-methylpyridin-3-yl)oxybutoxy}phenyl)-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(2,3,4-trifluorophenoxy)butoxyphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(2,3,6-trifluorophenoxy)butoxyphenyl}-3-methylbutan-1-one;
1-(2-hydroxy-4-{4-(2-iodopyridin-3-yl)oxybutoxy}-3-methylphenyl)-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(5,6,7,8-tetrahydroquinolin-3-yloxy)butoxyphenyl}-3-methylbutan-1-one;
7-{3-2-bromo-3-hydroxy-4-(3-methylbutanoyl)phenoxypropoxy}-2H-chromen-2-one;
1-{3-bromo-2-hydroxy-4-4-(2-pyridin-2-yl-1H-benzimidazol-1-yl)butoxyphenyl}-3-methylbutan-1-one;
1-(4-{4-(2,6-dimethylpyridin-3-yl)oxybutoxy}-2-hydroxy-3-methylphenyl)-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(pyridin-4-ylthio)butoxyphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(4-pyrimidin-2-ylpiperazin-1-yl)butoxyphenyl}-3-methylbutan-1-one;
1-{4-4-(2,3-dichlorophenoxy)butoxy-2-hydroxy-3-methylphenyl}-3-methylbutan-1-one;
1-{3-bromo-2-hydroxy-4-4-(5,6,7,8-tetrahydroquinolin-3-yloxy)butoxyphenyl}-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-{4-(2,3,5,6-tetrafluorophenyl)thiobutoxy}phenyl)-3-methylbutan-1-one;
1-(4-{4-(5-bromopyridin-3-yl)oxybutoxy}-2-hydroxy-3-methylphenyl)-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(3-pyridin-2-ylphenoxy)butoxyphenyl}-3-methylbutan-1-one;
methyl-3-(2-hydroxy-4-{4-3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxybutoxy}-phenyl)propanoate;
1-(2-hydroxy-3-methyl-4-{4-2-(1,3-thiazol-4-yl)-1H-benzimidazol-1-ylbutoxy}phenyl)-3-methylbutan-1-one;
1-(4-{4-(3-fluorophenyl)thiobutoxy}-2-hydroxy-3-methylphenyl)-3-methylbutan-1-one;
5-{3-(4-Acetyl-3-hydroxy-2-propylphenoxy)methylphenoxy}pyridine-2-carbonitrile;
1-{2-hydroxy-3-methyl-4-4-(4-pyridin-2-ylphenoxy)butoxyphenyl}-3-methylbutan-1-one;
1-{4-4-(1H-benzimidazol-1-yl)butoxy-2-hydroxy-3-methylphenyl}-3-methylbutan-1-one;
(1-{4-3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxybutyl}-1H-benzimidazol-2-yl)acetonitrile;

1-(2-hydroxy-3-methyl-4-{4-2-(trifluoromethyl)-1H-benzimidazol-1-ylbutoxy}phenyl)-3-methylbutan-1-one;
1-{3-(4-acetyl-3-hydroxy-2-propylphenoxy)methylbenzyl}azetidine-3-carbonitrile;
1-{4-4-(1,3-benzothiazol-2-ylthio)butoxy-2-hydroxy-3-methylphenyl}-3-methylbutan-1-one;
1-(4-{4-(6-chloro-1,3-benzoxazol-2-yl)thiobutoxy}-2-hydroxy-3-methylphenyl)-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(2-phenyl-1H-imidazol-1-yl)butoxyphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(2-phenyl-1H-benzimidazol-1-yl)butoxyphenyl}-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{4-(1-methyl-1H-tetrazol-5-yl)thiobutoxy}phenyl)-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(quinolin-3-yloxy)butoxyphenyl}-3-methylbutan-1-one;
1-{4-4-(1,3-benzoxazol-2-ylthio)butoxy-2-hydroxy-3-methylphenyl}-3-methylbutan-1-one;
1-(4-{4-(5-chloro-1,3-benzoxazol-2-yl)thiobutoxy}-2-hydroxy-3-methylphenyl)-3-methylbutan-1-one;
1-{2-hydroxy-4-4-(1H-indol-1-yl)butoxy-3-methylphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(7H-purin-6-ylthio)butoxyphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(2-phenyl-1H-indol-1-yl)butoxyphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(pyridin-4-ylsulfonyl)butoxyphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(pyridin-3-ylthio)butoxyphenyl}-3-methylbutan-1-one;
3\u2032-(4-Acetyl-3-hydroxy-2-propylphenoxy)methylbiphenyl-2-carbonitrile;
1-hydroxy-3-{4-3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxybutoxy}pyridinium;
1-{2-hydroxy-3-methyl-4-4-(4-methyl-2-phenyl-1H-imidazol-1-yl)butoxyphenyl}-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{4-2-(methylthio)-1H-benzimidazol-1-ylbutoxy}phenyl)-3-methylbutan-1-one;
1-(3-bromo-4-{4-(6-chloro-1,3-benzoxazol-2-yl)thiobutoxy}-2-hydroxyphenyl)-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(4-phenyl-1H-imidazol-1-yl)butoxyphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(pyridin-2-ylthio)butoxyphenyl}-3-methylbutan-1-one;
1-(4-{4-2-(2-chlorophenyl)-1H-benzimidazol-1-ylbutoxy}-2-hydroxy-3-methylphenyl)-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{4-(1-oxidopyridin-2-yl)thiobutoxy}phenyl)-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{5-(2-phenyl-1H-benzimidazol-1-yl)pentyloxy}phenyl)-3-methylbutan-1-one;
7-{4-3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxybutoxy}chroman-2-one;
1-(2-hydroxy-3-methyl-4-{4-4-(3-oxobutyl)phenoxybutoxy}phenyl)-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{3-(pyridin-4-ylthio)benzyloxy}phenyl)-3-methylbutan-1-one;
1-4-(4-{2-(2-fluorophenyl)-1H-benzimidazol-1-yloxy}butoxy)-2-hydroxy-3-methylphenyl-3-methylbutan-1-one;
1-4-(4-{2-(4-fluorophenyl)-1H-benzimidazol-1-yloxy}butoxy)-2-hydroxy-3-methylphenyl-3-methylbutan-1-one;
1-(4-{4-2-(2,4-dichlorophenyl)-1H-imidazol-1-ylbutoxy}-2-hydroxy-3-methylphenyl)-3-methylbutan-1-one;
1-4-(4-{2-(3-chlorophenyl)-1H-benzimidazol-1-yloxy}butoxy)-2-hydroxy-3-methylphenyl-3-methylbutan-1-one;
7-{4-3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxybutoxy}-2,3-dihydro-4H-chromen-4-one;
1-(2-hydroxy-4-{4-4-(3-hydroxypropyl)phenoxybutoxy}-3-methylphenyl)-3-methylbutan-1-one;
methyl 3-(4-{4-3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxybutoxy}phenyl)-propanoate;
1-{2-hydroxy-4-2-(6-hydroxy-1-benzofuran-3-yl)ethoxy-3-methylphenyl}-3-methylbutan-1-one;
methyl 2-hydroxy-4-{4-3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxybutoxy}-benzoate;
ethyl 7-{4-3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxybutoxy}chromane-2-carboxylate;
1-{3-chloro-2,4-bis4-(pyridin-4-ylthio)butoxyphenyl}-3-methylbutan-1-one;
1-{3-bromo-2-hydroxy-4-4-(pyridin-4-ylthio)butoxyphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-3-methyl-4-4-(pyridin-4-ylthio)butoxyphenyl}-3,3-dimethylbutan-1-one;
1-2-hydroxy-3-methyl-4-({3-(pyridin-4-ylthio)methylbenzyl}oxy)phenyl-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{4-(2-phenyl-1H-benzimidazol-1-yl)oxybutoxy}phenyl)-3,3-dimethylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{4-(pyridin-4-ylthio)benzyloxy}phenyl)-3-methylbutan-1-one;
1-{2-hydroxy-4-4-(3-hydroxyphenoxy)butoxy-3-methylphenyl}-3-methylbutan-1-one;
1-{4-4-(3,4-dihydro-2H-chromen-7-yloxy)butoxy-2-hydroxy-3-methylphenyl}-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{4-(pyridin-4-ylthio)benzyloxy}phenyl)-3,3-dimethylbutan-1-one;
1-(3-bromo-2-hydroxy-4-{4-(pyridin-4-ylthio)benzyloxy}phenyl)-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{3-(pyridin-4-ylthio)benzyloxy}phenyl)-3,3-dimethylbutan-1-one;
3\u2032-{4-(3,3-dimethylbutanoyl)-3-hydroxy-2-methylphenoxymethyl}biphenyl-3-carboxamide;
1-(3-bromo-2-hydroxy-4-{4-(2-phenyl-1H-benzimidazol-1-yl)oxybutoxy}phenyl)-3-methylbutan-1-one;
1-2-hydroxy-3-methyl-4-({4-(pyridin-4-ylthio)methylbenzyl}oxy)phenyl-3-methylbutan-1-one;
1-2-hydroxy-4-({3-methoxy-4-(pyridin-4-ylthio)methylbenzyl}oxy)-3-methylphenyl-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{2-(pyridin-4-ylthio)benzyloxy}phenyl)-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{4-(2-methylpyridin-4-yl)thiobutoxy}phenyl)-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{3-(pyridin-3-ylamino)benzyloxy}phenyl)-3-methylbutan-1-one;
1-2-hydroxy-3-methyl-4-({3-(pyridin-4-ylthio)methylbenzyl}oxy)phenyl-3,3-dimethylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{3-(pyridin-2-ylamino)benzyloxy}phenyl)-3-methylbutan-1-one;
1-(2-hydroxy-3-methyl-4-{3-(pyridin-4-ylamino)benzyloxy}phenyl)-3-methylbutan-1-one;
1-{2-hydroxy-4-4-(1H-indazol-5-yloxy)butoxy-3-methylphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-4-4-(1H-indazol-6-yloxy)butoxy-3-methylphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-4-4-(1H-indol-4-yloxy)butoxy-3-methylphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-4-4-(1H-indol-5-yloxy)butoxy-3-methylphenyl}-3-methylbutan-1-one;
1-{2-hydroxy-4-4-(1H-indol-6-yloxy)butoxy-3-methylphenyl}-3-methylbutan-1-one;
ethyl 5-(3-{3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxymethyl}phenyl)amino-2-methoxybenzoate;
1-2-hydroxy-4-({3-(3-methoxyphenyl)aminobenzyl}oxy)-3-methylphenyl-3-methylbutan-1-one;
1-4-({3-(3-ethoxyphenyl)aminobenzyl}oxy)-2-hydroxy-3-methylphenyl-3-methylbutan-1-one;
1-2-hydroxy-4-({3-(3-isopropylphenyl)aminobenzyl}oxy)-3-methylphenyl-3-methylbutan-1-one;
1-2-hydroxy-3-methyl-4-({3-methyl(pyridin-2-yl)aminobenzyl}oxy)phenyl-3-methylbutan-1-one;
1-{2-(benzyloxy)-3-methyl-4-4-(pyridin-4-ylthio)butoxyphenyl}-3-methylbutan-1-one;
or a pharmaceutically acceptable salt thereof.
46. A pharmaceutical composition which comprises an inert carrier and a compound of claim 28 or a pharmaceutically acceptable salt thereof.
47. A method for potentiation of metabotropic glutamate receptor activity in a mammal which comprises the administration of an effective amount of the compound of claim 28 or a pharmaceutically acceptable salt thereof.
48. A method for treating, controlling, ameliorating or reducing the risk of a neurological and psychiatric disorders associated with glutamate dysfunction in a mammalian patient in need of such which comprises administering to the patient a therapeutically effective amount of a compound of claim 28 or a pharmaceutically acceptable salt thereof.
49. A method for treating, controlling, ameliorating or reducing the risk of anxiety in a mammalian patient in need of such which comprises administering to the patient a therapeutically effective amount of a compound of claim 28 or a pharmaceutically acceptable salt thereof.
50. A method for treating, controlling, ameliorating or reducing the risk of depression in a mammalian patient in need of such which comprises administering to the patient a therapeutically effective amount of a compound of claim 28 or a pharmaceutically acceptable salt thereof.
51. A method for treating, controlling, ameliorating or reducing the risk of schizophrenia in a mammalian patient in need of such which comprises administering to the patient a therapeutically effective amount of a compound of claim 28 or a pharmaceutically acceptable salt thereof.
52. A method for treating, controlling, ameliorating or reducing the risk of epilepsy in a mammalian patient in need of such which comprises administering to the patient a therapeutically effective amount of a compound of claim 28 or a pharmaceutically acceptable salt thereof.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A lens antenna assembly comprising a hemispherical lens made of a dielectric material for converging radio wave, a radio wave reflecting plate having a greater diameter than the hemispherical lens and provided on the flat surface of the hemispherical lens, a feed for receiving and transmitting radio wave, the feed being movable to a focal point of the hemispherical lens, and a reflecting plate support means for supporting the radio wave reflecting plate so as to be inclinable in any desired direction, thereby adjusting the inclination angle of the reflecting plate such that the incidence angle of radio waves incident on the hemispherical lens will be within a predetermined range.
2. The lens antenna assembly of claim 1 further comprising a position setting means for moving the feed to the focal point, the position setting means comprising an azimuth angle setting means for controlling the azimuth angle of the feed in a direction in which radio waves enters the hemispherical lens by moving the feed around an azimuth axis of the hemispherical lens, and an elevation angle setting means for controlling the elevation angle of the feed in a direction in which radio waves enters the hemispherical lens by moving the feed around an elevation axis of the hemispherical lens.
3. The lens antenna assembly of claim 1 or 2 wherein the reflecting plate support means comprises a base, a hemispherical or spherical member pivotally mounted on the base and supporting the reflecting plate, and an inclination angle setting means connected to the base.
4. The lens antenna assembly of claim 3 wherein the inclination angle setting means includes a mechanism for adjusting the inclination of the reflecting plate by inclining the reflecting plate if an incidence angle of radio waves incident on the hemispherical lens is outside of a predetermined range of 20 to 80 degrees so that the incidence angle will be within the range of 20 to 80 degrees.
5. The lens antenna assembly of claim 4 wherein the incidence angle is 45 to 60 degrees.
6. The lens antenna assembly of claim 5 further comprising a radome for protecting the hemispherical lens and the feed.